Edit |   |
---|---|
Antigenic Specificity | CD80, Human (Galiximab biosimilar) |
Clone | Galiximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD80 Recombinant Antibody. Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009, it is undergoing Phase III clinical trials. The drug is a chimeric antibody from Macaca irus and Homo sapiens. |
Immunogen | n/a |
Other Names | Anti-CD80 Recombinant Antibody, Research Grade Galiximab, Anti-Human CD80 Recombinant Antibody, IDEC-114, Antibody Drug Analogues, Monoclonal Antibody, YR1092, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 357613-77-5 |
Catalog # | YR1092 |
Price | please inquire |
Order / More Info | CD80, Human (Galiximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |